Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs. Metastasis is ...
A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression ...
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified the specific cells responsible for gastric cancer's tendency to return after treatment. The study also ...
FDA approval covers adult BPDCN in both newly diagnosed and relapsed/refractory disease, leveraging breakthrough therapy, orphan drug designation, and priority review status. CADENZA enrolled 33 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results